Barry Labinger - Net Worth and Insider Trading
Barry Labinger Net Worth
The estimated net worth of Barry Labinger is at least $152,603 dollars as of 2024-09-24. Barry Labinger is the EVP, Biosciences Div. of Emergent BioSolutions Inc and owns about 25,182 shares of Emergent BioSolutions Inc (EBS) stock worth over $152,603. Details can be seen in Barry Labinger's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Barry Labinger has not made any transactions after 2015-11-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Barry Labinger
Barry Labinger Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Barry Labinger owns 2 companies in total, including Checkmate Pharmaceuticals Inc (CMPI) , and Emergent BioSolutions Inc (EBS) .
Click here to see the complete history of Barry Labinger’s form 4 insider trades.
Insider Ownership Summary of Barry Labinger
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CMPI | Checkmate Pharmaceuticals Inc | 2020-08-06 | director & President and CEO |
EBS | Emergent BioSolutions Inc | 2015-11-13 | EVP & Biosciences Div. |
Barry Labinger Latest Holdings Summary
Barry Labinger currently owns a total of 1 stock. Barry Labinger owns 25,182 shares of Emergent BioSolutions Inc (EBS) as of November 13, 2015, with a value of $152,603.
Latest Holdings of Barry Labinger
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
EBS | Emergent BioSolutions Inc | 2015-11-13 | 25,182 | 6.06 | 152,603 |
Holding Weightings of Barry Labinger
Barry Labinger Form 4 Trading Tracker
According to the SEC Form 4 filings, Barry Labinger has made a total of 0 transactions in Emergent BioSolutions Inc (EBS) over the past 5 years. The most-recent trade in Emergent BioSolutions Inc is the sale of 3,376 shares on November 13, 2015, which brought Barry Labinger around $123,224.
Insider Trading History of Barry Labinger
- 1
Barry Labinger Trading Performance
Barry Labinger Ownership Network
Barry Labinger Owned Company Details
What does Checkmate Pharmaceuticals Inc do?
Who are the key executives at Checkmate Pharmaceuticals Inc?
Barry Labinger is the director & President and CEO of Checkmate Pharmaceuticals Inc. Other key executives at Checkmate Pharmaceuticals Inc include 10 percent owner Venbio Global Strategic Fund Ii L.p. , director & Chief Executive Officer Alan Bash , and 10 percent owner Novo Holdings A/s .
Checkmate Pharmaceuticals Inc (CMPI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Checkmate Pharmaceuticals Inc (CMPI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Checkmate Pharmaceuticals Inc (CMPI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Checkmate Pharmaceuticals Inc (CMPI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Checkmate Pharmaceuticals Inc Insider Transactions
Barry Labinger Mailing Address
Above is the net worth, insider trading, and ownership report for Barry Labinger. You might contact Barry Labinger via mailing address: C/o Checkmate Pharmaceuticals, Inc., 245 Main Street, 2nd Floor, Cambridge Ma 02142.